Market Value958,473,386
Total Holdings93
File Date2023-02-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GTHX / G1 Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
DHR / Danaher Corporation
TECH / Bio-Techne Corporation
VRTX / Vertex Pharmaceuticals Incorporated
EPIX / ESSA Pharma Inc.
VRAY / ViewRay Inc.
SILK / Silk Road Medical, Inc
HUM / Humana Inc.
PHR / Phreesia, Inc.
AGL / agilon health, inc.
NKTR / Nektar Therapeutics
NVST / Envista Holdings Corporation
ABMD / Abiomed Inc.
SGMO / Sangamo Therapeutics, Inc.
JAZZ / Jazz Pharmaceuticals plc
BIIB / Biogen Inc.
PRVA / Privia Health Group, Inc.
PODD / Insulet Corporation
APLS / Apellis Pharmaceuticals, Inc.
IOVA / Iovance Biotherapeutics, Inc.
EW / Edwards Lifesciences Corporation
HZNP / Horizon Therapeutics Plc
PGNY / Progyny, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
RCM / R1 RCM Inc.
OSH / Oak Street Health Inc
NVCR / NovoCure Limited
NKTX / Nkarta, Inc.
MRSN / Mersana Therapeutics, Inc.
ABT / Abbott Laboratories
ALKS / Alkermes plc
RVNC / Revance Therapeutics, Inc.
VEEV / Veeva Systems Inc.
SGEN / Seagen Inc
JNJ / Johnson & Johnson
SWAV / Shockwave Medical, Inc.
XNCR / Xencor, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
EXAS / Exact Sciences Corporation
ISRG / Intuitive Surgical, Inc.
THC / Tenet Healthcare Corporation
ESPR / Esperion Therapeutics, Inc.
TXG / 10x Genomics, Inc.
HCAT / Health Catalyst, Inc.
COO / The Cooper Companies, Inc.
STXS / Stereotaxis, Inc.
RPID / Rapid Micro Biosystems, Inc.
MRTX / Mirati Therapeutics, Inc.
IQV / IQVIA Holdings Inc.
IGMS / IGM Biosciences, Inc.
GH / Guardant Health, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
TDOC / Teladoc Health, Inc.
ISEE / IVERIC bio Inc
REGN / Regeneron Pharmaceuticals, Inc.
HCA / HCA Healthcare, Inc.
OLK / Olink Holding AB (publ) - Depositary Receipt (Common Stock)
NTLA / Intellia Therapeutics, Inc.
PFE / Pfizer Inc.
ALHC / Alignment Healthcare, Inc.
UNH / UnitedHealth Group Incorporated
RPRX / Royalty Pharma plc
AXNX / Axonics, Inc.
IMGN / ImmunoGen, Inc.
WST / West Pharmaceutical Services, Inc.
ALLO / Allogene Therapeutics, Inc.
MGTX / MeiraGTx Holdings plc
BMRN / BioMarin Pharmaceutical Inc.
RLAY / Relay Therapeutics, Inc.
NUVL / Nuvalent, Inc.
GILD / Gilead Sciences, Inc.
MCK / McKesson Corporation
INSP / Inspire Medical Systems, Inc.
MDT / Medtronic plc
ELV / Elevance Health, Inc.
LLY / Eli Lilly and Company
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
NBIX / Neurocrine Biosciences, Inc.
ABBV / AbbVie Inc.
CI / The Cigna Group
NTRA / Natera, Inc.
CVS / CVS Health Corporation
ARVN / Arvinas, Inc.
OM / Outset Medical, Inc.
BSX / Boston Scientific Corporation
DVAX / Dynavax Technologies Corporation
CYTK / Cytokinetics, Incorporated
ITCI / Intra-Cellular Therapies, Inc.
COR / Cencora, Inc.
BDX / Becton, Dickinson and Company
GKOS / Glaukos Corporation
ALNY / Alnylam Pharmaceuticals, Inc.
IONS / Ionis Pharmaceuticals, Inc.
TMO / Thermo Fisher Scientific Inc.
MRK / Merck & Co., Inc.